Tresiba

Indicated For

Type 2 diabetes, Type 1 diabetes

About This Medication

# Novo Nordisk Patient Assistance Program Patient Guide: How to Get Tresiba (insulin degludec) at Low or No Cost Tresiba (insulin degludec) is a long-acting insulin used to help control blood sugar levels in adults and children with diabetes. The **Novo Nordisk Patient Assistance Program (PAP)** provides this medication **at no cost** to eligible patients who meet specific income and residency requirements, helping those who struggle with prescription costs.[1][2][4] ## About Tresiba and Why This Program Matters **Tresiba** is a once-daily basal insulin that offers flexible dosing times and lasts up to 42 hours, providing steady blood sugar control with a lower risk of hypoglycemia compared to some other insulins. It's prescribed for type 1 and type 2 diabetes. Managing diabetes requires consistent insulin use, but high costs—often hundreds of dollars per month—can be a barrier. The Novo Nordisk PAP removes this barrier by offering **free medication** for up to 12 months (or through year-end for Medicare patients), shipped directly to your doctor's office.[1][2][4] This guide explains eligibility, application steps, and what to expect, making it easy for you to access Tresiba without financial stress. ## Who Qualifies for the Program? To qualify, you must meet these key criteria: - Be a **U.S. citizen or legal resident** with a valid Social Security number.[4][5] - Have a **household income at or below 400% of the Federal Poverty Level (FPL)**. Eligibility is determined individually based on program guidelines.[1][4] - Not be eligible for Medicaid (or have a denial letter if applicable). Medicare Part D patients no longer need to spend $1,000 out-of-pocket—recent updates removed this requirement.[2][3] - Lack adequate prescription coverage, though exceptions apply.[10] **Income Eligibility Breakdown** Income limits are based on **400% of the 2026 Federal Poverty Level (FPL)**. Use this table as a guide (actual amounts may vary slightly; call 866-310-7549 to confirm your household size).[4] | Household Size | Annual Income Limit (400% FPL) | |----------------|-------------------------------| | 1 (Individual) | $60,320 | | 2 (Couple) | $81,760 | | 3 | $103,200 | | 4 | $124,640 | *Add ~$21,440 per additional family member. Proof of income required (e.g., tax returns, pay stubs).[1][7]* ## Insurance Requirements - **No prescription insurance** (HMO/PPO) preferred, but Medicare Part D enrollees are now eligible without prior spending thresholds.[2][3] - **Medicaid**: Must apply and be denied; submit denial letter.[2][8] - **Medicare LIS**: Submit denial letter if applicable.[2] - The program verifies insurance electronically with your consent.[1] Patients agree not to seek reimbursement from government programs.[1] ## Step-by-Step Application Process Applying is straightforward with **online or paper options**. Involves both you and your healthcare provider (HCP).[2][7] 1. **Gather Documents**: - Proof of income (2025 tax return, pay stubs, SSA-1099).[1][7] - Medicare card/Insurance ID if applicable.[1] - HCP's name, state, email.[7] - Medicaid/Medicare LIS denial letter if relevant.[2] 2. **Choose Application Method**: - **Online** (English only): HCP starts at novocare.com, you complete patient section via email link.[2][7] - **Paper** (English/Spanish): Download from novocare.com, fill patient section, HCP completes prescriber/Rx, fax to 866-441-4190 or mail to Novo Nordisk, PO Box 370, Somerville, NJ 08876.[1][4] - **Phone Help**: Call **866-310-7549** (M-F 8am-8pm ET).[1][7] 3. **Sign and Submit**: Patient and HCP sign; consent to electronic income/insurance verification.[1] 4. **Opt-Ins**: Choose SMS, phone alerts, or TPCA (pre-recorded calls).[1][2] ## Timeline and Delivery - **Processing**: 2 business days if complete; up to 10 business days otherwise. Allow extra for mail.[1][2][7] - **Decision**: Mailed letter to you/HCP; phone/text if opted in.[2] - **Delivery**: If approved, **10-14 business days (up to 21 days)** to HCP's office for coordinated dispensing. **Direct-to-patient shipment** available in some cases.[1][2] - **Enrollment**: 12 months; Medicare through year-end.[4] ## Alternatives if Denied or Ineligible - **Reapply**: Fix issues (e.g., missing docs) and resubmit.[2] - **Other NovoCare Savings**: My$99Insulin (insulin at $99/month), copay cards.[9] - **State Programs**: Check Medicaid, state pharmaceutical aid.[8] - **NeedyMeds.org** or 211.org for generics/biosimilars (none specified for Tresiba).[7] - **HCP Samples** or clinic resources. ## Refills and Reauthorization Approved patients get 90-day supplies. **Reapply annually** or as notified; HCP submits reorder form.[5] Track via phone alerts.[1] ## Important Disclaimer This guide is for informational purposes based on current program details as of 2026. Eligibility, rules, and FPL change; **always verify with Novo Nordisk at 866-310-7549 or novocare.com**. Not legal/medical advice. Consult your doctor before starting Tresiba. Program free—no fees.[1][4] (Word count: 942)

Program information last verified: March 30, 2026